Table of Contents

May 5, 2005
Volume 48, Issue 9
Pages 3095-3448

About the Cover: Interaction of the β-L-enantiomer of a 4'-C-ethynyl-2',3'-dideoxynucleoside analogue (ent-14-TP) at the active site of HIV reverse transcriptase (Siddiqui, M. A.; et al. J. Med. Chem. 2004, 47, 5041-5048).

Letters

Discovery of a β-MSH-Derived MC-4R Selective Agonist

pp 3095–3098
Publication Date (Web): April 12, 2005 (Letter)
DOI: 10.1021/jm0501432

Synthesis and Biological Evaluation of Aminopolyamines

pp 3099–3102
Publication Date (Web): April 02, 2005 (Letter)
DOI: 10.1021/jm050024m

Discovery of Diphenyloxazole and Nδ-Z-Ornithine Derivatives as Highly Potent and Selective Human Prostaglandin EP4 Receptor Antagonists

pp 3103–3106
Publication Date (Web): April 13, 2005 (Letter)
DOI: 10.1021/jm050085k

Identification and Structure−Activity Relationship of Phenolic Acyl Hydrazones as Selective Agonists for the Estrogen-Related Orphan Nuclear Receptors ERRβ and ERRγ

pp 3107–3109
Publication Date (Web): April 12, 2005 (Letter)
DOI: 10.1021/jm050161j

Toward a Novel Class of Antithrombotic Compounds with Dual Function. Discovery of 1,4-Benzoxazin-3(4H)-one Derivatives Possessing Thrombin Inhibitory and Fibrinogen Receptor Antagonistic Activities

pp 3110–3113
Publication Date (Web): March 30, 2005 (Letter)
DOI: 10.1021/jm048984g

Thyroid Receptor Ligands. 3. Design and Synthesis of 3,5-Dihalo-4-alkoxyphenylalkanoic Acids as Indirect Antagonists of the Thyroid Hormone Receptor

pp 3114–3117
Publication Date (Web): April 06, 2005 (Letter)
DOI: 10.1021/jm050004k

1-(5-Chloro-2-alkoxyphenyl)-3-(5-cyano- pyrazi-2-yl)ureas as Potent and Selective Inhibitors of Chk1 Kinase:  Synthesis, Preliminary SAR, and Biological Activities

pp 3118–3121
Publication Date (Web): April 02, 2005 (Letter)
DOI: 10.1021/jm048989d

“In Situ Cross-Docking” To Simultaneously Address Multiple Targets

pp 3122–3125
Publication Date (Web): April 09, 2005 (Letter)
DOI: 10.1021/jm050075j

Thermodynamic Analysis of Interactions between N-Linked Sugar Chains and F-Box Protein Fbs1

pp 3126–3129
Publication Date (Web): April 08, 2005 (Letter)
DOI: 10.1021/jm0489511

Articles

Bisphosphonate Inhibitors of Toxoplasma gondi Growth:  In Vitro, QSAR, and In Vivo Investigations

pp 3130–3140
Publication Date (Web): April 02, 2005 (Article)
DOI: 10.1021/jm040132t

Discovery of 3-[(4,5,7-Trifluorobenzothiazol-2-yl)methyl]indole-N-acetic Acid (Lidorestat) and Congeners as Highly Potent and Selective Inhibitors of Aldose Reductase for Treatment of Chronic Diabetic Complications

pp 3141–3152
Publication Date (Web): March 30, 2005 (Article)
DOI: 10.1021/jm0492094

Morphiceptin Analogues Containing a Dipeptide Mimetic Structure:  An Investigation on the Bioactive Topology at the μ-Receptor

pp 3153–3163
Publication Date (Web): April 02, 2005 (Article)
DOI: 10.1021/jm040867y

A Bioavailability Score

pp 3164–3170
Publication Date (Web): April 05, 2005 (Article)
DOI: 10.1021/jm0492002

Enantiomerically Pure Hexahydropyrazinoquinolines as Potent and Selective Dopamine 3 Subtype Receptor Ligands

pp 3171–3181
Publication Date (Web): April 02, 2005 (Article)
DOI: 10.1021/jm049031l

HierS:  Hierarchical Scaffold Clustering Using Topological Chemical Graphs

pp 3182–3193
Publication Date (Web): April 08, 2005 (Article)
DOI: 10.1021/jm049032d

Synthesis and Antibacterial Activity of 1-(2-Fluorovinyl)-7-substituted-4-quinolone-3-carboxylic Acid Derivatives, Conformationally Restricted Analogues of Fleroxacin

pp 3194–3202
Publication Date (Web): April 02, 2005 (Article)
DOI: 10.1021/jm0402061

Successful in Silico Discovery of Novel Nonsteroidal Ligands for Human Sex Hormone Binding Globulin

pp 3203–3213
Publication Date (Web): April 02, 2005 (Article)
DOI: 10.1021/jm049087f

DASH:  A Novel Analysis Method for Molecular Dynamics Simulation Data. Analysis of Ligands of PPAR-γ

pp 3214–3220
Publication Date (Web): March 18, 2005 (Article)
DOI: 10.1021/jm049216s

Frontal Affinity Chromatography with MS Detection of EphB2 Tyrosine Kinase Receptor. 2. Identification of Small-Molecule Inhibitors via Coupling with Virtual Screening

pp 3221–3230
Publication Date (Web): April 12, 2005 (Article)
DOI: 10.1021/jm0492204

On the Binding of Indeno[1,2-c]isoquinolines in the DNA−Topoisomerase I Cleavage Complex

pp 3231–3238
Publication Date (Web): April 02, 2005 (Article)
DOI: 10.1021/jm050017y

Ligand-Based Prediction of Active Conformation by 3D-QSAR Flexibility Descriptors and Their Application in 3+3D-QSAR Models

pp 3239–3250
Publication Date (Web): March 31, 2005 (Article)
DOI: 10.1021/jm049157i

Molecular Dynamics Simulation of the Ligand Binding Domain of Farnesoid X Receptor. Insights into Helix-12 Stability and Coactivator Peptide Stabilization in Response to Agonist Binding

pp 3251–3259
Publication Date (Web): April 09, 2005 (Article)
DOI: 10.1021/jm049182o

Synthesis and Cytotoxic Evaluation of Combretafurazans

pp 3260–3268
Publication Date (Web): April 13, 2005 (Article)
DOI: 10.1021/jm049096o

Calculating Virtual log P in the Alkane/Water System (log PNalk) and Its Derived Parameters Δlog PNoct-alk and log DpHalk

pp 3269–3279
Publication Date (Web): April 02, 2005 (Article)
DOI: 10.1021/jm048980b

Identification of Novel Low Molecular Weight CXCR4 Antagonists by Structural Tuning of Cyclic Tetrapeptide Scaffolds

pp 3280–3289
Publication Date (Web): April 13, 2005 (Article)
DOI: 10.1021/jm050009h

Structural Requirements for Factor Xa Inhibition by 3-Oxybenzamides with Neutral P1 Substituents:  Combining X-ray Crystallography, 3D-QSAR, and Tailored Scoring Functions

pp 3290–3312
Publication Date (Web): April 13, 2005 (Article)
DOI: 10.1021/jm049187l

Conformation Mining:  An Algorithm for Finding Biologically Relevant Conformations

pp 3313–3318
Publication Date (Web): April 09, 2005 (Article)
DOI: 10.1021/jm049066l

Structure−Activity Relationships of Fluorinated Lysophosphatidic Acid Analogues

pp 3319–3327
Publication Date (Web): April 02, 2005 (Article)
DOI: 10.1021/jm049186t

N-Terminal Fatty Acylated His-dPhe-Arg-Trp-NH2 Tetrapeptides:  Influence of Fatty Acid Chain Length on Potency and Selectivity at the Mouse Melanocortin Receptors and Human Melanocytes

pp 3328–3336
Publication Date (Web): March 30, 2005 (Article)
DOI: 10.1021/jm0490843

Synthesis and Pharmacology of 6-Substituted Benztropines:  Discovery of Novel Dopamine Uptake Inhibitors Possessing Low Binding Affinity to the Dopamine Transporter

pp 3337–3343
Publication Date (Web): April 05, 2005 (Article)
DOI: 10.1021/jm0490235

Class II (IIa)-Selective Histone Deacetylase Inhibitors. 1. Synthesis and Biological Evaluation of Novel (Aryloxopropenyl)pyrrolyl Hydroxyamides

pp 3344–3353
Publication Date (Web): April 07, 2005 (Article)
DOI: 10.1021/jm049002a

Symmetrical Bis-Quinolinium Compounds:  New Human Choline Kinase Inhibitors with Antiproliferative Activity against the HT-29 Cell Line

pp 3354–3363
Publication Date (Web): April 13, 2005 (Article)
DOI: 10.1021/jm049061o

Platinum(II) Complexes with Antitumoral/Antiviral Aromatic Heterocycles:  Effect of Glutathione upon in Vitro Cell Growth Inhibition

pp 3364–3371
Publication Date (Web): April 08, 2005 (Article)
DOI: 10.1021/jm0500471

Synthesis and Biological Evaluation of 14-Alkoxymorphinans. 22.1 Influence of the 14-Alkoxy Group and the Substitution in Position 5 in 14-Alkoxymorphinan-6-ones on in Vitro and in Vivo Activities

pp 3372–3378
Publication Date (Web): April 09, 2005 (Article)
DOI: 10.1021/jm040894o

Design of Benzophenone-Containing Photoactivatable Linear Vasopressin Antagonists:  Pharmacological and Photoreactive Properties

pp 3379–3388
Publication Date (Web): April 07, 2005 (Article)
DOI: 10.1021/jm040871+

Adenosine Kinase Inhibitors. 4. 6,8-Disubstituted Purine Nucleoside Derivatives. Synthesis, Conformation, and Enzyme Inhibition

pp 3389–3399
Publication Date (Web): April 07, 2005 (Article)
DOI: 10.1021/jm048968j

C-5-Disubstituted Barbiturates as Potential Molecular Probes for Noninvasive Matrix Metalloproteinase Imaging

pp 3400–3409
Publication Date (Web): April 12, 2005 (Article)
DOI: 10.1021/jm049145x

Antitumor Effects of Two Novel Naturally Occurring Terpene Quinones Isolated from the Mediterranean Ascidian Aplidium conicum

pp 3410–3416
Publication Date (Web): April 12, 2005 (Article)
DOI: 10.1021/jm0489915

Synthesis and in Vitro and in Vivo Antitumor Activity of 2-Phenylpyrroloquinolin-4-ones

pp 3417–3427
Publication Date (Web): April 13, 2005 (Article)
DOI: 10.1021/jm049387x

Brief Articles

1,5-Diarylpyrrole-3-acetic Acids and Esters as Novel Classes of Potent and Highly Selective Cyclooxygenase-2 Inhibitors

pp 3428–3432
Publication Date (Web): April 12, 2005 (Brief Article)
DOI: 10.1021/jm049121q

Computational Strategies in Discovering Novel Non-nucleoside Inhibitors of HIV-1 RT

pp 3433–3437
Publication Date (Web): April 13, 2005 (Brief Article)
DOI: 10.1021/jm049279a

Convergent Synthesis and Pharmacology of Substituted Tetrazolyl-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid Analogues

pp 3438–3442
Publication Date (Web): April 08, 2005 (Brief Article)
DOI: 10.1021/jm050014l

Synthesis and Antibacterial Activity of the 4-Quinolone-3-carboxylic Acid Derivatives Having a Trifluoromethyl Group as a Novel N-1 Substituent

pp 3443–3446
Publication Date (Web): April 13, 2005 (Brief Article)
DOI: 10.1021/jm040204g

Book Reviews

New Drug Approval Process. Accelerating Global Registrations. 4th Edition Edited by Richard A. Guarino. Marcel Dekker, New York. 2004. xiv + 635 pp. 16 × 23.5 cm. ISBN 0824750411. $164.00.

p 3447
Publication Date (Web): March 31, 2005 (Book Review)
DOI: 10.1021/jm058202z
p 3448
Publication Date (Web): March 29, 2005 (Book Review)
DOI: 10.1021/jm058193u